Lacetti P, Tombaccini D, Aloj S, Grollman E F, Kohn L D
Adv Exp Med Biol. 1984;174:355-67. doi: 10.1007/978-1-4684-1200-0_30.
The thyrotropin (TSH) receptor has been proposed to be composed of a membrane glycoprotein and a membrane ganglioside, the former important in high affinity recognition, the latter vital for message coupling to the adenylate cyclase system. The present study used two approaches, formation of antireceptor monoclonal antibodies and reconstitution, to validate the model and further examine the role of the ganglioside. Three kinds of monoclonal antireceptor antibodies are defined. One group which inhibits TSH binding and TSH functions, i.e., TSH-stimulated adenylate cyclase activity, iodide uptake, and thyroid hormone release, is shown to be directed against the glycoprotein component of the receptor. The second group includes antibodies which mimic TSH in all stimulatory actions, are competitive agonists of TSH, are equivalent to thyroid stimulating antibodies in the sera of patients with Graves' disease, and are directed against the ganglioside component of the receptor. These stimulating monoclonal antibodies are directed against a minor ganglioside membrane component which fractionates as a disialoganglioside. When this ganglioside is incorporated into 1-8 thyroid cells which have a correlated ganglioside deficiency and TSH receptor defect, reconstitution of TSH stimulated adenylate cyclase activity occurs. Whereas the first group of antibodies inhibits TSH-stimulated function, they do not inhibit the stimulatory antibodies which mimic TSH, an observation consistent with the 2 component hypothesis of the receptor model. The third group of antibodies have a mix of properties from the first two groups and suggests that the TSH receptor in situ is an actual complex of the two components or that there are common carbohydrate determinants in the functional sites of each receptor component. Implications of a TSH receptor structure in which its ganglioside and glycoprotein components are in equilibrium with pools of free components and, in turn, components important for cholera toxin, tetanus toxin and interferon receptors are discussed. In regard to the pathogenesis of Graves' disease, the data indicate that thyroid stimulating autoantibodies are autoimmune equivalents of cholera toxin with respect to the importance of ganglioside function. Since antiidiotype studies of antibodies against TSH confirm a structural relationship between receptors for thyrotropin, cholera toxin, and thyroid stimulating autoantibodies, the data establish an unequivocal role for the ganglioside in TSH receptor structure which facilitates interpretation of in vitro experiments aimed at understanding the mechanism of ganglioside-ligand interactions.
促甲状腺激素(TSH)受体被认为由一种膜糖蛋白和一种膜神经节苷脂组成,前者在高亲和力识别中起重要作用,后者对信息与腺苷酸环化酶系统的偶联至关重要。本研究采用两种方法,即抗受体单克隆抗体的形成和重组,来验证该模型并进一步研究神经节苷脂的作用。定义了三种单克隆抗受体抗体。一组抑制TSH结合和TSH功能,即TSH刺激的腺苷酸环化酶活性、碘摄取和甲状腺激素释放,已证明其针对受体的糖蛋白成分。第二组包括在所有刺激作用中模拟TSH的抗体,它们是TSH的竞争性激动剂,等同于格雷夫斯病患者血清中的甲状腺刺激抗体,并且针对受体的神经节苷脂成分。这些刺激性单克隆抗体针对一种作为双唾液酸神经节苷脂分级分离的次要神经节苷脂膜成分。当这种神经节苷脂被掺入具有相关神经节苷脂缺乏和TSH受体缺陷的1 - 8甲状腺细胞中时,会发生TSH刺激的腺苷酸环化酶活性的重组。虽然第一组抗体抑制TSH刺激的功能,但它们不抑制模拟TSH的刺激性抗体,这一观察结果与受体模型的双成分假说一致。第三组抗体具有前两组的混合特性,表明原位TSH受体是这两种成分的实际复合物,或者在每个受体成分的功能位点存在共同的碳水化合物决定簇。讨论了TSH受体结构的意义,其中其神经节苷脂和糖蛋白成分与游离成分池处于平衡状态,进而讨论了对霍乱毒素、破伤风毒素和干扰素受体重要的成分。关于格雷夫斯病的发病机制,数据表明甲状腺刺激自身抗体在神经节苷脂功能的重要性方面是霍乱毒素的自身免疫等效物。由于针对TSH的抗体的抗独特型研究证实了促甲状腺激素、霍乱毒素和甲状腺刺激自身抗体的受体之间的结构关系,这些数据确立了神经节苷脂在TSH受体结构中的明确作用,这有助于解释旨在理解神经节苷脂 - 配体相互作用机制的体外实验。